Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Zhengye Biotechnology Holding Ltd ZYBT

Healthcare Drug Manufacturers - Specialty & Generic
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for... see more

Current News (NDAQ:ZYBT)

Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results

PR Newswire July 3, 2025

Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F

GlobeNewswire May 23, 2025

Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option

GlobeNewswire January 14, 2025

Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering

GlobeNewswire January 8, 2025

Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering

GlobeNewswire January 6, 2025
View More News ››

Opinion & Analysis (NDAQ:ZYBT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ZYBT)

Be the first to post on this bullboard.

TomaGold Corp.

TomaGold Corp.

TomaGold Corporation, together with its subsidiaries, engages in the acquisition, exploration, assessment, and development of ...
View More »